Article

CD8-positive T cells are key immune cells for predicting the therapeutic effect of neoadjuvant chemotherapy in triple-negative breast cancer

2024-06-07

Abstract excerpt

<title>Abstract</title> <p>Background Patients with triple-negative breast cancer who obtain a pathological complete response after neoadjuvant chemotherapy have an improved prognosis. The existence of tumour-infiltrating lymphocytes (TILs) in breast cancer is also an independent prognostic factor, and lymphocyte-predominant breast cancer is more likely to respond to neoadjuvant chemotherapy. However, the detail...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5d86213a-a178-5932-8d46-31da1781fc58
DOI: 10.21203/rs.3.rs-4446081/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CD8-positive T cells are key immune cells for predicting the therapeutic effect of neoadjuvant chemotherapy in triple-negative breast cancerDOI 10.21203/rs.3.rs-4446081/v1Read

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Semantic proximity Read

Classification of triple-negative breast cancer based on immune cell infiltrationSemantic proximity Read

A Comprehensive Immunologic Portrait of Triple-Negative Breast CancerSemantic proximity Read

Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysisSemantic proximity Read

Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy.Semantic proximity Read

Toll Like Receptor 4 and IFNγ Signalling axis as a therapeutic target in Triple negative Breast CancerSemantic proximity Read

Association between levels of tumor-infiltrating lymphocytes in different subtypes of primary breast tumors and prognostic outcomes: A meta-analysisSemantic proximity Read

Outcome Prediction after Neoadjuvant Chemotherapy (NAC) for Breast Cancer, using Tumor-Infiltrating Lymphocytes within Fibrotic Foci of Tumor Stroma (FF-TILs)Semantic proximity Read

A scoring screening system based on machine learning for immunotherapy beneficiaries in triple-negative breast cancerSemantic proximity Read

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancerSemantic proximity Read

Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancerSemantic proximity Read

Advances in immunotherapy for triple-negative breast cancerSemantic proximity Read